Cutera Inc yesterday announced today that it is postponing indefinitely the release of its TruSculpt body contouring product.

Kevin Connors, CEO commented, "We have had the opportunity to review recent clinical data from our research and have determined that established clinical protocols have not yielded the desired outcome. We believe the potential market for non-invasive body contouring is very large; however, our standards for product performance are higher than is commercially available. We have a strong history of introducing leading products with a high level of clinical efficacy that ensure customer success."

He concluded, "We will continue our research efforts, including the monitoring of our clinical sites, and will commercialize the technology, if and when it has met the standards our customers have come to expect from us. This decision will allow us to redirect some of our resources on other exciting development projects."

[Source: Associated Press]